Back
Nuveen Enhanced Yield US Aggregate Bond ETF Vs. Guardant Health, Inc. Industry Stock Comparison
Sell
40
NUAG
Nuveen Enhanced Yield US Aggregate Bond ETF
Last Price:
$21.24
Seasonality Move:
-0.45%
Buy
60
GH
Guardant Health, Inc.
Last Price:
$103.00
Seasonality Move:
10.65%
Sell
40
Nuveen Enhanced Yield US Aggregate Bond ETF (NUAG)
is a Sell
Is Nuveen Enhanced Yield US Aggregate Bond ETF a Buy, Sell or Hold?
-
The current Nuveen Enhanced Yield US Aggregate Bond ETF [NUAG] share price is $21.22. The Score for NUAG is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
NUAG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Guardant Health, Inc. (GH)
is a Buy
Is Guardant Health, Inc. a Buy, Sell or Hold?
-
The current Guardant Health, Inc. [GH] share price is $102.98. The Score for GH is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
GH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NUAG Stock Price Chart
What is Nuveen Enhanced Yield US Aggregate Bond ETF's stock price today?
-
The Nuveen Enhanced Yield US Aggregate Bond ETF share price today is $21.22Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUAG is experiencing selling pressure, which indicates risk of future bearish movement.
GH Stock Price Chart
What is Guardant Health, Inc.'s stock price today?
-
The Guardant Health, Inc. share price today is $102.98Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GH is experiencing slight selling pressure.
NUAG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 47.97 | Sell |
| Chaikin Money Flow: | -26162 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.18 - 21.32) | Sell |
| Bollinger Bands (100): | (21.12 - 21.38) | Sell |
GH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.51 | Buy |
| Relative Strength Index (14 RSI): | 56.88 | Buy |
| Chaikin Money Flow: | -91277 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (100.02 - 106.96) | Sell |
| Bollinger Bands (100): | (57.42 - 97.1) | Buy |
NUAG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.2 | Buy |
| 20-day SMA: | 21.24 | Sell |
| 50-day SMA: | 21.3 | Sell |
| 200-day SMA: | 21.02 | Buy |
| 8-day EMA: | 21.21 | Buy |
| 20-day EMA: | 21.23 | Sell |
| 50-day EMA: | 20.93 | Buy |
| 200-day EMA: | 13.74 | Buy |
GH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 100.44 | Buy |
| 20-day SMA: | 102.68 | Buy |
| 50-day SMA: | 94.48 | Buy |
| 200-day SMA: | 61.25 | Buy |
| 8-day EMA: | 101.63 | Buy |
| 20-day EMA: | 101.15 | Buy |
| 50-day EMA: | 93.64 | Buy |
| 200-day EMA: | 67.25 | Buy |
Nuveen Enhanced Yield US Aggregate Bond ETF Earnings Growth & NUAG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Guardant Health, Inc. Earnings Growth & GH Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and an increase next year of $0.36 per share.
Nuveen Enhanced Yield US Aggregate Bond ETF Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Guardant Health, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||